FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

WASHINGTON — FDA Commissioner Martin Makary offered more details into the agency’s recently announced plans to place ...

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The FDA is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, part of a bid to get faster and leaner in evaluating drugs, foods, medical devices and diagnostic ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing ...

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...

The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...

The U.S. Food and Drug Administration (FDA) on Thursday announced an expedited plan to implement artificial intelligence (AI) across all FDA centers by June 30 in a bid to speed up the review ...